Cyclopharm Presentation - FNN Investor Event - Sep 2018
Cyclopharm Managing Director & CEO, James McBrayer presents an update on its radiopharmaceutical products used in imaging, sales of Technegas and its US FDA application.
– Cyclopharm Limited is a leading diagnostic lung imaging company
– Profitable & Growing MedTech
– USA FDA approval set to increase growth
– First in class technology in the 56 countries
– 4M Technegas patient scans
– Opportunity to broaden Technegas applications beyond pulmonary embolism diagnosis
For more information, watch Managing Director & CEO James McBrayer present.